- Labeler
- Ranbaxy Pharmaceuticals Inc.
- Dosage Form
- SUSPENSION
- Route
- ORAL
- NDCs
- 63304-768-03, 63304-768-01, 63304-768-04, 63304-768-07, 63304-768-50, 63304-768-02
- DailyMed
- Open label page
- Fetched At
- 2026-04-18 12:57:18.294322+00:00
Active Ingredients
| Display Name | UNII | Strength | Source |
|---|---|---|---|
| AMOXICILLIN | 804826J2HU | 600 mg/5 mL | Structured XML |
| CLAVULANATE POTASSIUM | Q42OMW3AT8 | 42.9 mg/5 mL | Structured XML |
Parsed Inactive Ingredients
| Display Name | UNII | Source |
|---|---|---|
| ASPARTAME | Z0H242BBR1 | Structured XML |
| SILICON DIOXIDE | ETJ7Z6XBU4 | Structured XML |
| MONOSODIUM CITRATE | 68538UP9SE | Structured XML |
| SODIUM CITRATE | 1Q73Q2JULR | Structured XML |
| XANTHAN GUM | TTV12P4NEE | Structured XML |
Debug Details
Record Metadata
- SETID
- 08a35bfc-3945-4f95-948a-8af36cda715c
Inactive Ingredients Raw Text
ASPARTAME, SILICON DIOXIDE, MONOSODIUM CITRATE, SODIUM CITRATE, XANTHAN GUM
Active Ingredient Debug View
| Display Name | Normalized | UNII | Strength | Source | Confidence | Raw Source Text |
|---|---|---|---|---|---|---|
| AMOXICILLIN | AMOXICILLIN | 804826J2HU | 600 mg/5 mL | Structured XML | medium | AMOXICILLIN |
| CLAVULANATE POTASSIUM | CLAVULANATE POTASSIUM | Q42OMW3AT8 | 42.9 mg/5 mL | Structured XML | medium | CLAVULANATE POTASSIUM |
Inactive Ingredient Debug View
| Display Name | Normalized | UNII | Strength | Source | Confidence | Raw Source Text |
|---|---|---|---|---|---|---|
| ASPARTAME | ASPARTAME | Z0H242BBR1 | Unavailable | Structured XML | medium | ASPARTAME |
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | Unavailable | Structured XML | medium | SILICON DIOXIDE |
| MONOSODIUM CITRATE | MONOSODIUM CITRATE | 68538UP9SE | Unavailable | Structured XML | medium | MONOSODIUM CITRATE |
| SODIUM CITRATE | SODIUM CITRATE | 1Q73Q2JULR | Unavailable | Structured XML | medium | SODIUM CITRATE |
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | Unavailable | Structured XML | medium | XANTHAN GUM |